Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedNo substantive changes to the study details were observed; the differences seem limited to page presentation.SummaryDifference0.1%

- Check22 days agoChange DetectedNo changes detected between the two screenshots; the study page content appears unchanged.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a behind-the-scenes version upgrade with no visible changes to study content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site revision label updated from v3.4.2 to v3.4.3. This appears to be a routine maintenance update.SummaryDifference0.1%

- Check44 days agoChange DetectedUI and layout adjustments observed between the two screenshots; core study details and eligibility criteria remain unchanged.SummaryDifference0.1%

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.